Page 144 - Pagetit

4. PSYCHOPHARMACOLOGY OF DEPENDENCE FOR DIFFERENT DRUG CLASSES

Volkow ND et al. (1996) Cocaine addiction: hypothesis derived from imaging
studies with PET. Journal of Addictive Diseases, 15:55–71.
Volkow ND et al. (1999) Reinforcing effects of psychostimulants in humans are
associated with increases in brain dopamine and occupancy of D2 receptors.
Journal of Pharmacology and Experimental Therapeutics, 291:409–415.
Volkow ND et al. (2001a) Low level of brain dopamine D2 receptors in
methamphetamine abusers: association with metabolism in the orbitofrontal
cortex. American Journal of Psychiatry, 158:2015–2021.
Volkow ND et al. (2001b) Association of dopamine transporter reduction with
psychomotor impairment in methamphetamine abusers. American Journal of
Psychiatry, 158:377–382.
Von Euler G et al. (1993) Persistent effects of subchronic toluene exposure on
spatial learning and memory, dopamine-mediated locomotor activity and
dopamine D2 agonist binding in the rat. Toxicology, 77:223–232.
Wang GJ et al. (2000) Regional brain metabolism during alcohol intoxication.
Alcoholism: Clinical and Experimental Research, 24:822–829.
Weir E (2001) Inhalant use and addiction in Canada. Canadian Medical
Association Journal, 164:397.
Weiss B, Wood RW, Macys DA (1979) Behavioral toxicology of carbon disulfide
and toluene. Environmental Health Perspectives, 30:39–45.
Wettstein JG, Gauthier B (1992) Discriminative stimulus effects of alprazolam
and diazepam: generalization to benzodiazepines, antidepressants and
buspirone. Behavioural Pharmacology, 3:229–237.
WHO (1994) Lexicon of alcohol and drug terms. Geneva, World Health
Organization.
WHO (1997a) Cannabis: a health perspective and research agenda. Geneva, World
Health Organization (document WHO/MSA/PSA/97.4).
WHO (1997b) Amphetamine-type stimulants: a report from the WHO Meeting on
Amphetamines, MDMA and other Psychostimulants, Geneva, 12-15 November
1996. Geneva, World Health Organization (document WHO/MSA/PSA/97.5).
WHO (1998) Expert committee on drug dependence: thirtieth report. Geneva, World
Health Organization (WHO Technical Report Series, No. 873).
WHO (1999) Volatile solvents abuse: a global overview. Geneva, World Health
Organization (document WHO/HSC/SAB/99.7).
WHO (2001) Ecstasy: MDMA and other ring-substituted amphetamines. Geneva,
World Health Organization (document WHO/MSD/MSB/01.3).
Williams JT, Christie MJ, Manzoni O (2001) Cellular and synaptic adaptations
mediating opioid dependence. Physiological Reviews, 81:299–343.
Wise RA, Bozarth MA (1987) A psychomotor stimulant theory of addiction.
Psychological Reviews, 94:469–492.
Woolverton WL, Johnson KM (1992) Neurobiology of cocaine abuse. Trends in
Pharmacological Sciences, 13:193–200.

123

Chapter_4 123 19.1.2004, 11:44